Luuk J. Kalverdijk

1.4k total citations
19 papers, 594 citations indexed

About

Luuk J. Kalverdijk is a scholar working on Psychiatry and Mental health, Clinical Psychology and Pediatrics, Perinatology and Child Health. According to data from OpenAlex, Luuk J. Kalverdijk has authored 19 papers receiving a total of 594 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Psychiatry and Mental health, 7 papers in Clinical Psychology and 6 papers in Pediatrics, Perinatology and Child Health. Recurrent topics in Luuk J. Kalverdijk's work include Attention Deficit Hyperactivity Disorder (14 papers), Child and Adolescent Psychosocial and Emotional Development (7 papers) and Pharmaceutical studies and practices (6 papers). Luuk J. Kalverdijk is often cited by papers focused on Attention Deficit Hyperactivity Disorder (14 papers), Child and Adolescent Psychosocial and Emotional Development (7 papers) and Pharmaceutical studies and practices (6 papers). Luuk J. Kalverdijk collaborates with scholars based in Netherlands, United States and United Kingdom. Luuk J. Kalverdijk's co-authors include Catharina C. M. Schuiling‐Veninga, Julie M. Zito, Mehmet Burcu, Christian Bachmann, Linda Wijlaars, Gerd Glaeske, Falk Hoffmann, Ruud B. Minderaa, Lolkje T.W. de Jong‐van den Berg and Hilde Tobi and has published in prestigious journals such as Journal of Clinical Epidemiology, Psychiatric Services and British Journal of Clinical Pharmacology.

In The Last Decade

Luuk J. Kalverdijk

18 papers receiving 581 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Luuk J. Kalverdijk Netherlands 12 419 205 149 147 51 19 594
Carla Allan United States 6 652 1.6× 328 1.6× 225 1.5× 135 0.9× 24 0.5× 10 864
Anna M. Wehry United States 10 210 0.5× 350 1.7× 167 1.1× 73 0.5× 29 0.6× 11 617
Morris Zwi United Kingdom 11 592 1.4× 232 1.1× 229 1.5× 94 0.6× 58 1.1× 21 746
Sílvia Amoretti Spain 15 481 1.1× 258 1.3× 124 0.8× 36 0.2× 46 0.9× 65 789
Martha X Sajatovic United States 10 517 1.2× 179 0.9× 66 0.4× 49 0.3× 64 1.3× 14 708
Michael Koelch Germany 12 158 0.4× 238 1.2× 116 0.8× 81 0.6× 33 0.6× 27 452
Sean R. Zion United States 10 136 0.3× 150 0.7× 132 0.9× 59 0.4× 69 1.4× 23 498
Calvin R. Sumner United States 15 767 1.8× 293 1.4× 292 2.0× 101 0.7× 57 1.1× 25 916
Lin Sikich United States 7 372 0.9× 298 1.5× 98 0.7× 100 0.7× 23 0.5× 9 595
Duk‐In Jon South Korea 17 536 1.3× 258 1.3× 95 0.6× 68 0.5× 220 4.3× 100 889

Countries citing papers authored by Luuk J. Kalverdijk

Since Specialization
Citations

This map shows the geographic impact of Luuk J. Kalverdijk's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Luuk J. Kalverdijk with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Luuk J. Kalverdijk more than expected).

Fields of papers citing papers by Luuk J. Kalverdijk

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Luuk J. Kalverdijk. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Luuk J. Kalverdijk. The network helps show where Luuk J. Kalverdijk may publish in the future.

Co-authorship network of co-authors of Luuk J. Kalverdijk

This figure shows the co-authorship network connecting the top 25 collaborators of Luuk J. Kalverdijk. A scholar is included among the top collaborators of Luuk J. Kalverdijk based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Luuk J. Kalverdijk. Luuk J. Kalverdijk is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

19 of 19 papers shown
1.
Rosmalen, Judith G.M., et al.. (2024). Development of Gender Non-Contentedness During Adolescence and Early Adulthood. Archives of Sexual Behavior. 53(5). 1813–1825. 8 indexed citations
2.
Kloosterboer, Sanne, Catharina C. M. Schuiling‐Veninga, Jens Bos, et al.. (2018). Antipsychotics in Dutch Youth: Prevalence, Dosages, and Duration of Use from 2005 to 2015. Journal of Child and Adolescent Psychopharmacology. 28(3). 173–179. 18 indexed citations
3.
Bachmann, Christian, Linda Wijlaars, Luuk J. Kalverdijk, et al.. (2017). Trends in ADHD medication use in children and adolescents in five western countries, 2005–2012. European Neuropsychopharmacology. 27(5). 484–493. 91 indexed citations
4.
Kalverdijk, Luuk J., Christian Bachmann, Lise Aagaard, et al.. (2017). A multi-national comparison of antipsychotic drug use in children and adolescents, 2005–2012. Child and Adolescent Psychiatry and Mental Health. 11(1). 55–55. 53 indexed citations
5.
Vries, Ymkje Anna de, Peter de Jonge, Luuk J. Kalverdijk, et al.. (2016). Poor guideline adherence in the initiation of antidepressant treatment in children and adolescents in the Netherlands: choice of antidepressant and dose. European Child & Adolescent Psychiatry. 25(11). 1161–1170. 9 indexed citations
6.
Bachmann, Christian, Lise Aagaard, Mehmet Burcu, et al.. (2016). Trends and patterns of antidepressant use in children and adolescents from five western countries, 2005–2012. European Neuropsychopharmacology. 26(3). 411–419. 127 indexed citations
7.
Stoyanova‐Beninska, Violeta, Tamar Wohlfarth, Maria Isaac, et al.. (2010). The EU paediatric regulation:. European Neuropsychopharmacology. 21(8). 565–570. 11 indexed citations
8.
Faber, Adrianne, Luuk J. Kalverdijk, Lolkje T.W. de Jong‐van den Berg, et al.. (2009). Co-morbidity and patterns of care in stimulant-treated children with ADHD in the Netherlands. European Child & Adolescent Psychiatry. 19(2). 159–166. 15 indexed citations
9.
Wohlfarth, Tamar, Luuk J. Kalverdijk, Carin M. A. Rademaker, et al.. (2009). Psychopharmacology for children: From off label use to registration. European Neuropsychopharmacology. 19(8). 603–608. 8 indexed citations
10.
Janknegt, Robert, Adrianne Faber, Rob Rodrigues Pereira, & Luuk J. Kalverdijk. (2009). InforMatrix for attention deficit hyperactivity disorder. Expert Opinion on Pharmacotherapy. 10(5). 755–772. 1 indexed citations
11.
Visser, Sipke T., et al.. (2009). Large increase of the use of psycho‐stimulants among youth in the Netherlands between 1996 and 2006. British Journal of Clinical Pharmacology. 67(4). 466–468. 30 indexed citations
12.
Faber, Adrianne, Michel van Agthoven, Luuk J. Kalverdijk, et al.. (2008). Long-Acting Methylphenidate-OROS in Youths with Attention-Deficit Hyperactivity Disorder Suboptimally??Controlled with Immediate-Release Methylphenidate. CNS Drugs. 22(2). 157–170. 21 indexed citations
13.
Kalverdijk, Luuk J., et al.. (2008). Use of Antipsychotic Drugs Among Dutch Youths Between 1997 and 2005. Psychiatric Services. 59(5). 554–560. 65 indexed citations
14.
Kalverdijk, Luuk J., et al.. (2008). Use of Antipsychotic Drugs Among Dutch Youths Between 1997 and 2005. Psychiatric Services. 59(5). 554–560. 18 indexed citations
15.
Troost, Pieter W., Mark‐Peter Steenhuis, H. Tuynman-Qua, et al.. (2006). Atomoxetine for Attention-Deficit/Hyperactivity Disorder Symptoms in Children with Pervasive Developmental Disorders: APilot Study. Journal of Child and Adolescent Psychopharmacology. 16(5). 611–619. 64 indexed citations
16.
Faber, Adrianne, Luuk J. Kalverdijk, Lolkje T.W. de Jong‐van den Berg, et al.. (2006). Parents Report on Stimulant-Treated Children in the Netherlands: Initiation of Treatment and Follow-Up Care. Journal of Child and Adolescent Psychopharmacology. 16(4). 432–440. 17 indexed citations
17.
Buitelaar, Jan K., Joanne Barton, Marina Danckaerts, et al.. (2006). A comparison of North American versus non-North American ADHD study populations. European Child & Adolescent Psychiatry. 15(3). 177–181. 34 indexed citations
18.
Faber, Adrianne, Michel van Agthoven, Luuk J. Kalverdijk, et al.. (2006). PMH17 COST-EFFECTIVENESS OF LONG ACTING METHYLPHENIDATE-OROS IN ADHD YOUTHS WITH SUBOPTIMAL SYMPTOM CONTROL ON IMMEDIATE-RELEASE METHYLPHENIDATE IN THE NETHERLANDS. Value in Health. 9(6). A314–A315.
19.
Faber, Adrianne, et al.. (2005). Recruitment of parents and physicians of stimulant-using children via community pharmacies is successful. Journal of Clinical Epidemiology. 58(10). 1072–1073. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Carla Allan Breakdown of academic impact, for papers by Anna M. Wehry Breakdown of academic impact, for papers by Morris Zwi Breakdown of academic impact, for papers by Sílvia Amoretti Breakdown of academic impact, for papers by Martha X Sajatovic Breakdown of academic impact, for papers by Michael Koelch Breakdown of academic impact, for papers by Sean R. Zion Breakdown of academic impact, for papers by Calvin R. Sumner Breakdown of academic impact, for papers by Lin Sikich Breakdown of academic impact, for papers by Duk‐In Jon
Rankless by CCL
2026